KR940001885A - Antidepressant - Google Patents

Antidepressant Download PDF

Info

Publication number
KR940001885A
KR940001885A KR1019920012506A KR920012506A KR940001885A KR 940001885 A KR940001885 A KR 940001885A KR 1019920012506 A KR1019920012506 A KR 1019920012506A KR 920012506 A KR920012506 A KR 920012506A KR 940001885 A KR940001885 A KR 940001885A
Authority
KR
South Korea
Prior art keywords
antidepressant
excipient
aglycone
pharmaceutically acceptable
active ingredient
Prior art date
Application number
KR1019920012506A
Other languages
Korean (ko)
Inventor
정홍근
Original Assignee
정홍근
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 정홍근 filed Critical 정홍근
Priority to KR1019920012506A priority Critical patent/KR940001885A/en
Publication of KR940001885A publication Critical patent/KR940001885A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

Abstract

본 발명은 다음 일반식(1)로 표시되는 화합물, 그 아그리콘 및 그 약학적으로 허용되는 염을 유효성분 함유하고 통상의 보조제 또는 부형제를 함유하는 항우울제에 관한 것이다.The present invention relates to an antidepressant containing the compound represented by the following general formula (1), its aglycone and its pharmaceutically acceptable salts as an active ingredient and a conventional adjuvant or excipient.

식중 R은 수소 또는 메틸기이며, R1은 수소 또는 글루코오스 잔기 이다.Wherein R is hydrogen or methyl and R 1 is hydrogen or glucose moiety.

Description

항우울제Antidepressant

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

제1도는 UIB를 포함한 항우울제가 처곰 정지상태까지 지속된 흰쥐의 수영시간에 미치는 영향을 그래프로 나타낸 것이다.Figure 1 graphically shows the effect of antidepressants, including UIB, on swimming time in rats that persisted until the resting period.

Claims (5)

다음 일반구조식(1)로 표시되는 글리코사이드, 그 아그리콘 및 약학적으로 허용되는 염을 유효성분으로 함유하고 통상의 보조제 또는 부형제를 함유하는 항우울제.An antidepressant containing glycoside represented by the following general structural formula (1), its aglycone and a pharmaceutically acceptable salt as an active ingredient and a conventional adjuvant or excipient. 실중 R은 수소 또는 메틸기이며. R1은 수소 또는 글루로오스 잔기이다.Actual R is hydrogen or methyl group. R 1 is hydrogen or glurose residue. 제1항에서 상기 일반식(1)로 표시되는 글리코사이드 그 아그리콘 및 약학적으로 허용되는 염을 유효성분으로 함유하고 통상의 주사용제제 제조용 보조제 또는 부형제를 함유하는 주사제 형태의 항우울제.An antidepressant in the form of an injection containing the glycoside aglycone represented by the general formula (1) and a pharmaceutically acceptable salt thereof as an active ingredient and an adjuvant or excipient for preparing a conventional injectable preparation. 제1항에 상기 일반식(1)의 글리코사이드 그 아그리콘, 및 약학적으로 허용 되는 염을 유효성분으로 함유하고 통상의 산제 제조용 보조제 또는 부형제를 함유한 산제형태의 항우울제.An antidepressant in the form of a powder according to claim 1, wherein the glycoside aglycone of the general formula (1) and a pharmaceutically acceptable salt are contained as an active ingredient and a conventional powder preparation auxiliary or excipient. 제1항에 상기 일반식(1)의 글리코사이드, 그 아그리콘, 및 약학적으로 허용되는 염을 유효성분으로 함유하고 통상의 정제제조용 보조제 또는 부형제를 함유하고 정제형태로 타정한 항우울제.The antidepressant of claim 1, wherein the glycoside of Formula (1), its aglycone, and a pharmaceutically acceptable salt are contained as an active ingredient, and a conventional tablet preparation adjuvant or excipient is compressed into tablet form. 제1항에 상기 일반식(1)의 글리코사이드, 그 아그리콘, 및 약학적으로 허용되는 염을 유효성분으로 함유하고 통상의 캡슐제 제조용 보조제 또는 부형제를 함유하고 캡슐제형태로 제형화된 항우울제.An antidepressant formulated in a capsule form according to claim 1, wherein the glycoside of Formula (1), its aglycone, and a pharmaceutically acceptable salt are contained as an active ingredient, and contain an adjuvant or excipient for preparing a conventional capsule. . ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019920012506A 1992-07-14 1992-07-14 Antidepressant KR940001885A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019920012506A KR940001885A (en) 1992-07-14 1992-07-14 Antidepressant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019920012506A KR940001885A (en) 1992-07-14 1992-07-14 Antidepressant

Publications (1)

Publication Number Publication Date
KR940001885A true KR940001885A (en) 1994-02-16

Family

ID=67147028

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920012506A KR940001885A (en) 1992-07-14 1992-07-14 Antidepressant

Country Status (1)

Country Link
KR (1) KR940001885A (en)

Similar Documents

Publication Publication Date Title
KR940001886A (en) Pharmaceutical preparations that inhibit the replication of hepatitis B virus (HBV)
KR950017957A (en) Preparation and intermediates of 3, 4, 4-trisubstituted-piperidinyl-N-alkylcarboxylates
DE69328192D1 (en) Injectable pharmaceutical preparations containing taxane derivatives
BR9507640A (en) Process for stabilizing duocarmicide derivatives and pharmaceutical composition
ES2017836A6 (en) 4H-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
KR930703303A (en) 1,4-benzothiazepine derivative
EA200200147A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PHENOPHYDRATE AND METHOD FOR ITS PREPARATION
ES514267A0 (en) "A PROCEDURE FOR THE PREPARATION OF PIRROLIDINE DERIVATIVES".
KR900009606A (en) Fluorine-containing 2-nitroimidazole derivatives and radiation sensitizers containing them
KR920005984A (en) Pharmaceutical Compositions Containing Furan Derivatives
KR950703941A (en) Nitrogen monoxide synthase inhibitor (NITROGEN MONOXIDE SYNTHESIS INHIBITOR)
KR900001715A (en) BU-3608 derivative
KR940001885A (en) Antidepressant
CA2215659A1 (en) Morphinan hydroxamic acid compounds
GB1289240A (en)
KR930012018A (en) Pharmaceutical composition
KR970704723A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents (DIHYDROBENZOFURAN AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS)
JPS6431727A (en) Dissolution of argininamide and drug composition containing argininamides
IT1115155B (en) PHARMACEUTICAL PREPARATION CONTAINING A DERIVED ORTHO-AMINOBENZOIC ACID AS ACTIVE INGREDIENT
KR880013938A (en) Active compounds
ES486049A1 (en) Aminopropanol derivatives of 6-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-ones, process for their preparation, and pharmaceutical compositions containing them.
KR910019625A (en) How to suppress bone mineral loss
KR940021524A (en) 1,2,5,6-tetrahydropyridine derivatives, preparation method thereof and use thereof in treatment
CA2054738A1 (en) 15-deoxyprostaglandin derivatives
ES2051750T3 (en) PROCEDURE FOR THE PREPARATION OF NEW COMPOUNDS.

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination